Patents by Inventor Kensuke Kawasaki

Kensuke Kawasaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11935784
    Abstract: A vertical layer stack including a bit-line-level dielectric layer and an etch stop dielectric layer can be formed over an array region. Bit-line trenches are formed through the vertical layer stack. Bit-line-trench fill structures are formed in the bit-line trenches. Each of the bit-line-trench fill structures includes a stack of a bit line and a capping dielectric strip. At least one via-level dielectric layer can be formed over the vertical layer stack. A bit-line-contact via cavity can be formed through the at least one via-level dielectric layer and one of the capping dielectric strips. A bit-line-contact via structure formed in the bit-line-contact via cavity includes a stepped bottom surface including a top surface of one of the bit lines, a sidewall segment of the etch stop dielectric layer, and a segment of a top surface of the etch stop dielectric layer.
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: March 19, 2024
    Assignee: SANDISK TECHNOLOGIES LLC
    Inventors: Fumitaka Amano, Yusuke Osawa, Kensuke Ishikawa, Mitsuteru Mushiga, Motoki Kawasaki, Shinsuke Yada, Masato Miyamoto, Syo Fukata, Takashi Kashimura, Shigehiro Fujino
  • Patent number: 8946173
    Abstract: The present invention provides a drug capable of causing cancer cells to restore anticancer drug sensitivity in cases in which cancer has acquired resistance to an anticancer drug and inducing cell death in cancer cells. The present invention specifically provides a cancer cell death inducing agent comprising REIC/Dkk-3 DNA as an active ingredient and having effects of potentiating an anticancer drug for cancer cells having anticancer drug resistance.
    Type: Grant
    Filed: November 5, 2008
    Date of Patent: February 3, 2015
    Assignee: Momotaro-Gene Inc.
    Inventors: Hiromi Kumon, Yasutomo Nasu, Masami Watanabe, Yuji Kashiwakura, Kensuke Kawasaki
  • Publication number: 20110269824
    Abstract: The present invention provides a drug capable of causing cancer cells to restore anticancer drug sensitivity in cases in which cancer has acquired resistance to an anticancer drug and inducing cell death in cancer cells. The present invention specifically provides a cancer cell death inducing agent comprising REIC/Dkk-3 DNA as an active ingredient and having effects of potentiating an anticancer drug for cancer cells having anticancer drug resistance.
    Type: Application
    Filed: November 5, 2008
    Publication date: November 3, 2011
    Applicant: Momotaro-Gene Inc.
    Inventors: Hiromi Kumon, Yasutomo Nasu, Masami Watanabe, Yuji Kashiwakura, Kensuke Kawasaki